Willow Biosciences (TSE:WLLW) Shares Down 33.3% – Should You Sell?

Shares of Willow Biosciences Inc. (TSE:WLLWGet Free Report) were down 33.3% during mid-day trading on Tuesday . The company traded as low as C$0.02 and last traded at C$0.02. Approximately 1,001,532 shares changed hands during mid-day trading, an increase of 144% from the average daily volume of 410,374 shares. The stock had previously closed at C$0.03.

Willow Biosciences Trading Down 50.0 %

The stock has a 50-day moving average of C$0.04 and a 200 day moving average of C$0.07. The company has a quick ratio of 19.71, a current ratio of 0.80 and a debt-to-equity ratio of 902.05. The stock has a market cap of C$2.17 million, a PE ratio of -0.27 and a beta of 1.13.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.